Logo image of GLBZ

GLEN BURNIE BANCORP (GLBZ) Stock Fundamental Analysis

NASDAQ:GLBZ - US3774071019 - Common Stock

4.12 USD
-0.01 (-0.24%)
Last: 8/28/2025, 8:14:27 PM
Fundamental Rating

2

Overall GLBZ gets a fundamental rating of 2 out of 10. We evaluated GLBZ against 393 industry peers in the Banks industry. GLBZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GLBZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year GLBZ was profitable.
In the past year GLBZ has reported a negative cash flow from operations.
GLBZ had positive earnings in 4 of the past 5 years.
GLBZ had a positive operating cash flow in each of the past 5 years.
GLBZ Yearly Net Income VS EBIT VS OCF VS FCFGLBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M 4M

1.2 Ratios

GLBZ has a worse Return On Assets (0.01%) than 89.82% of its industry peers.
Looking at the Return On Equity, with a value of 0.20%, GLBZ is doing worse than 89.57% of the companies in the same industry.
Industry RankSector Rank
ROA 0.01%
ROE 0.2%
ROIC N/A
ROA(3y)0.28%
ROA(5y)0.36%
ROE(3y)5.88%
ROE(5y)5.84%
ROIC(3y)N/A
ROIC(5y)N/A
GLBZ Yearly ROA, ROE, ROICGLBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

The Profit Margin of GLBZ (0.31%) is worse than 89.82% of its industry peers.
The Operating Margin and Gross Margin are not available for GLBZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 0.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLBZ Yearly Profit, Operating, Gross MarginsGLBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

GLBZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GLBZ has more shares outstanding
GLBZ has more shares outstanding than it did 5 years ago.
GLBZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GLBZ Yearly Shares OutstandingGLBZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
GLBZ Yearly Total Debt VS Total AssetsGLBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

GLBZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC12.09%
GLBZ Yearly LT Debt VS Equity VS FCFGLBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLBZ Yearly Current Assets VS Current LiabilitesGLBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for GLBZ have decreased strongly by -94.17% in the last year.
Looking at the last year, GLBZ shows a decrease in Revenue. The Revenue has decreased by -2.39% in the last year.
The Revenue has been decreasing by -2.72% on average over the past years.
EPS 1Y (TTM)-94.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.54%
Revenue 1Y (TTM)-2.39%
Revenue growth 3Y-2.54%
Revenue growth 5Y-2.72%
Sales Q2Q%-2.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLBZ Yearly Revenue VS EstimatesGLBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 412.00 indicates a quite expensive valuation of GLBZ.
89.06% of the companies in the same industry are cheaper than GLBZ, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.17, GLBZ is valued quite expensively.
Industry RankSector Rank
PE 412
Fwd PE N/A
GLBZ Price Earnings VS Forward Price EarningsGLBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLBZ Per share dataGLBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GLBZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLEN BURNIE BANCORP

NASDAQ:GLBZ (8/28/2025, 8:14:27 PM)

4.12

-0.01 (-0.24%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-29 2025-10-29
Inst Owners8.05%
Inst Owner Change24.38%
Ins Owners14.68%
Ins Owner Change1.37%
Market Cap11.95M
Analysts0
Price TargetN/A
Short Float %0.36%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)-5.82%
DP1521.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 412
Fwd PE N/A
P/S 0.99
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.62
EV/EBITDA N/A
EPS(TTM)0.01
EY0.24%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS4.16
BVpS6.61
TBVpS6.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.31%
GM N/A
FCFM N/A
ROA(3y)0.28%
ROA(5y)0.36%
ROE(3y)5.88%
ROE(5y)5.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC12.09%
ROIC/WACCN/A
Cap/Depr(3y)62.68%
Cap/Depr(5y)233.41%
Cap/Sales(3y)1.26%
Cap/Sales(5y)2.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.39%
Revenue growth 3Y-2.54%
Revenue growth 5Y-2.72%
Sales Q2Q%-2.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-122.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.66%
OCF growth 3Y-80.3%
OCF growth 5Y-60.71%